Higa Tomohiro 4
4 · Tenaya Therapeutics, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Tenaya (TNYA) SVP Finance Tomohiro Higa Sells 3,469 Shares
What Happened
Tomohiro Higa, Senior Vice President, Finance at Tenaya Therapeutics (TNYA), sold a total of 3,469 shares on February 17, 2026 in three open-market transactions (611; 836; 2,022 shares). The weighted average sales price was $0.64 per share (range $0.6075–$0.671), for aggregate proceeds of approximately $2,231. The Form 4 indicates these sales were made to cover tax-withholding obligations tied to previously granted restricted stock units (RSUs).
Key Details
- Transaction date: 2026-02-17 (filed same day). Transaction type: Sale (code S).
- Shares sold: 611, 836 and 2,022 (total 3,469). Weighted average price: $0.64; price range: $0.6075–$0.671. Total proceeds ≈ $2,231. (Per footnote F2, reporting person can provide a breakdown of number of shares sold at each price on request.)
- Purpose: Shares sold to cover tax withholding for vested RSUs (footnotes F1, F4, F6).
- Unvested RSUs disclosed: includes 78,314; 76,376; and 71,688 shares that will be issued upon vesting (footnotes F3, F5, F7).
- Shares owned after the transactions are not specified in the provided excerpt.
- Filing timeliness: Report appears to have been filed on the same day as the transactions (not flagged late).
Context
These sales are reported as tax-withholding transactions tied to RSU vesting, a common and routine insider sale (treated as a non-investment-motivated disposition). Such transactions generally do not imply a change in the insider’s view of the company’s prospects; they simply satisfy tax obligations associated with vesting.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-02-17$0.64/sh−611$393→ 122,610 total - Sale
Common Stock
[F4][F2][F5]2026-02-17$0.64/sh−836$538→ 121,774 total - Sale
Common Stock
[F6][F2][F7]2026-02-17$0.64/sh−2,022$1,300→ 119,752 total
Footnotes (7)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 78,314 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- [F5]Includes 76,376 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F6]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
- [F7]Includes 71,688 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.